A new rapid titration protocol for lamotrigine that reduces the risk of skin rash

OBJECTIVE: Lamotrigine is one of the most widely used antiepileptic drugs, but it has a critical issue of a skin rash if the starting dose is too high or the escalation rate is too rapid. We investigated the efficacy and safety of a novel and rapid titration protocol for lamotrigine that takes only...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Yoonhyuk, Moon, Jangsup, Kim, Narae, Kim, Tae‐Joon, Jun, Jin‐Sun, Shin, Yong‐Won, Chang, Hyeyeon, Kang, Hye‐Ryun, Lee, Soon‐Tae, Jung, Keun‐Hwa, Park, Kyung‐Il, Jung, Ki‐Young, Chu, Kon, Lee, Sang Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166783/
https://www.ncbi.nlm.nih.gov/pubmed/34033264
http://dx.doi.org/10.1002/epi4.12495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166783/
https://www.ncbi.nlm.nih.gov/pubmed/34033264
http://dx.doi.org/10.1002/epi4.12495

Ejemplares similares